Andrew H. Beck

3.8k citations

23 papers · 1.2k indexed · h-index 17

Cancer Research top 10%
- Breast Cancer Treatment Studies 4
- Cancer, Hypoxia, and Metabolism 3
Oncology top 10%
- Cancer Risks and Factors 3
Pulmonary and Respiratory Medicine top 10%
- Digital Radiography and Breast Imaging 4
Molecular Biology
- PI3K/AKT/mTOR signaling in cancer 3
- Ubiquitin and proteasome pathways 3
Pathology and Forensic Medicine
- Breast Lesions and Carcinomas 2
Artificial Intelligence
- AI in cancer detection 3

Co-authors: David M. Sabatini Brian C. Grabiner Kıvanç Birsoy Valentina Nardi Richard Possemato Sumi Sinha Kuang Shen Alexander C. Jordan
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: Nature (1 paper)Molecular Cell (1 paper)Bioinformatics (1 paper)
Partner nations: United States Australia United Kingdom

In The Last Decade

Andrew H. Beck

23 papers receiving 1.1k citations

Peers

Countries citing papers authored by Andrew H. Beck

Since Specialization

Citations

This map shows the geographic impact of Andrew H. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew H. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew H. Beck more than expected).

Fields of papers citing papers by Andrew H. Beck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew H. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew H. Beck. The network helps show where Andrew H. Beck may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrew H. Beck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew H. Beck Line = papers co-authored together Andrew H. Beck links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues Breast Cancer Research and Treatment ·Yujing J. Heng,Jun Wang,Thomas U. Ahearn,Susan B. Brown,Xuehong Zhang,Christine B. Ambrosone,Victor Piana de Andrade,Adam Brufsky,Fergus J. Couch,Tari A. King,Francesmary Modugno,Celine M. Vachon,Natalie Dupré,Montserrat García‐Closas,Melissa A. Troester,David J. Hunter,A. Heather Eliassen,Rulla M. Tamimi,Susan E. Hankinson,Andrew H. Beck	2018	22
2	Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes Breast Cancer Research and Treatment ·Lusine Yaghjyan,Rulla M. Tamimi,Kimberly A. Bertrand,Christopher G. Scott,Matthew R. Jensen,V. Shane Pankratz,Kathy R. Brandt,Daniel W. Visscher,Aaron D. Norman,Fergus J. Couch,John Shepherd,Bo Fan,Yunn-Yi Chen,Lin Ma,Andrew H. Beck,Steven R. Cummings,Karla Kerlikowske,Celine M. Vachon	2017	8
3	A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma Cancer Epidemiology Biomarkers & Prevention ·Fei Dong,Phani K. Davineni,Brooke E. Howitt,Andrew H. Beck	2016	13
4	Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling Cancer Research ·Whitney S. Henry,Tyler Laszewski,Tiffany Tsang,Francisco Beça,Andrew H. Beck,Sandra S. McAllister,Alex Toker	2016	103
5	Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status Cancer Epidemiology Biomarkers & Prevention ·Elizabeth E. Devore,Erica T. Warner,A. Heather Eliassen,Susan B. Brown,Andrew H. Beck,Susan E. Hankinson,Eva Schernhammer	2016	16
6	Safikhani et al. reply Nature ·Zhaleh Safikhani,Nehmé El-Hachem,Petr Smirnov,Mark Freeman,Anna Goldenberg,Nicolai J. Birkbak,Andrew H. Beck,Hugo J.W.L. Aerts,John Quackenbush,Benjamin Haibe‐Kains	2016	12
7	TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis? Human Pathology ·Mamta Gupta,Ana Babić,Andrew H. Beck,Kathryn L. Terry	2016	48
8	Systematic Analysis of Sex-Linked Molecular Alterations and Therapies in Cancer Scientific Reports ·Jonathan Ma,Sadhika Malladi,Andrew H. Beck	2016	18
9	Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms Journal of Clinical Pathology ·Thomas P. Ahern,Andrew H. Beck,Bernard Rosner,Benjamin Glass,Gretchen W. Frieling,Laura C. Collins,Rulla M. Tamimi	2016	15
10	Adult Body Size and Physical Activity in Relation to Risk of Breast Cancer According to Tumor Androgen Receptor Status Cancer Epidemiology Biomarkers & Prevention ·Xuehong Zhang,A. Heather Eliassen,Rulla M. Tamimi,Aditi Hazra,Andrew H. Beck,Myles Brown,Laura C. Collins,Bernard Rosner,Susan E. Hankinson	2015	16
11	SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression PMC ·Wenjian Gan,Xiangpeng Dai,Andrea Lunardi,Zhen Li,Hiroyuki Inuzuka,Pengda Liu,Shoreh Varmeh,Jinfang Zhang,Liang Cheng,Yin Sun,John M. Asara,Andrew H. Beck,Jiaoti Huang,Pier Paolo Pandolfi,Wenyi Wei	2015	1
12	Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers British Journal of Cancer ·Lusine Yaghjyan,Andreas Pettersson,Graham A. Colditz,Laura C. Collins,Stuart J. Schnitt,Andrew H. Beck,Bernard Rosner,Celine M. Vachon,Rulla M. Tamimi	2015	17
13	Noninvasive Imaging of Tumor Burden and Molecular Pathways in Mouse Models of Cancer Cold Spring Harbor Protocols ·Yuchuan Wang,Jen‐Chieh Tseng,Yanping Sun,Andrew H. Beck,Andrew L. Kung	2015	28
14	SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression Molecular Cell ·Wenjian Gan,Xiangpeng Dai,Andrea Lunardi,Zhen Li,Hiroyuki Inuzuka,Pengda Liu,Shoreh Varmeh,Jinfang Zhang,Liang Cheng,Yin Sun,John M. Asara,Andrew H. Beck,Jiaoti Huang,Pier Paolo Pandolfi,Wenyi Wei	2015	153
15	Dense and Nondense Mammographic Area and Risk of Breast Cancer by Age and Tumor Characteristics Cancer Epidemiology Biomarkers & Prevention ·Kimberly A. Bertrand,Christopher G. Scott,Rulla M. Tamimi,Matthew R. Jensen,V. Shane Pankratz,Aaron D. Norman,Daniel W. Visscher,Fergus J. Couch,John Shepherd,Yunn-Yi Chen,Bo Fan,Fang-Fang Wu,Lin Ma,Andrew H. Beck,Steven R. Cummings,Karla Kerlikowske,Celine M. Vachon	2015	39
16	The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors Applied immunohistochemistry & molecular morphology ·Ankur R. Sangoi,Bijayee Shrestha,G.Q. Yang,Ourhay Mego,Andrew H. Beck	2015	46
17	A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity Cancer Discovery ·Brian C. Grabiner,Valentina Nardi,Kıvanç Birsoy,Richard Possemato,Kuang Shen,Sumi Sinha,Alexander C. Jordan,Andrew H. Beck,David M. Sabatini	2014	318
18	A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity PMC ·David M. Sabatini,Brian C. Grabiner,Valentina Nardi,Kıvanç Birsoy,Richard Possemato,Kuang Shen,Sumi Sinha,Alexander C. Jordan,Andrew H. Beck	2014	17
19	The Adherens Junction Protein Afadin Is an AKT Substrate that Regulates Breast Cancer Cell Migration Molecular Cancer Research ·Sivan Elloul,Dmitriy Kedrin,Nicholas Knoblauch,Andrew H. Beck,Alex Toker	2013	40
20	Mammographic density and risk of breast cancer by age and tumor characteristics Breast Cancer Research ·Kimberly A. Bertrand,Rulla M. Tamimi,Christopher G. Scott,Matthew R. Jensen,V. Shane Pankratz,Daniel W. Visscher,Aaron D. Norman,Fergus J. Couch,John Shepherd,Bo Fan,Yunn‐Yi Chen,Lin Ma,Andrew H. Beck,Steven R. Cummings,Karla Kerlikowske,Celine M. Vachon	2013	141

About Andrew H. Beck

Andrew H. Beck is a scholar working on Cancer Research, Biophysics and Toxicology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Digital Radiography and Breast Imaging (4 papers), Cancer Risks and Factors (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), AI in cancer detection (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Ubiquitin and proteasome pathways (3 papers) and Breast Lesions and Carcinomas (2 papers). The work is most often cited by research in Cancer Research (291 citations), Oncology (324 citations) and Pulmonary and Respiratory Medicine (316 citations). Andrew H. Beck has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include David M. Sabatini, Brian C. Grabiner, Kıvanç Birsoy, Valentina Nardi, Richard Possemato, Sumi Sinha, Kuang Shen, Alexander C. Jordan, Alex Toker and Rulla M. Tamimi. Their work appears in journals such as Nature, Molecular Cell and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact